Luis Borges - Feb 2, 2023 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Signature
/s/ Michael Diem, Attorney-in-Fact
Stock symbol
IPSC
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
4
Date filed
2/6/2023, 05:50 PM
Previous filing
Jan 27, 2022
Next filing
Mar 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Award $0 +21.9K $0.00 21.9K Feb 2, 2023 Direct F1
transaction IPSC Common Stock Award $0 +21.9K +100% $0.00 43.8K Feb 2, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Award $0 +131K $0.00 131K Feb 2, 2023 Common Stock 131K $4.64 Direct F2
transaction IPSC Stock Option (right to buy) Award $0 +131K $0.00 131K Feb 2, 2023 Common Stock 131K $4.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the "Company's") common stock. The RSUs vest 25% on February 2, 2024 and the remaining 75% vest on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
F2 The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.